Home » Newsletters » BioWorld Science

BioWorld Science

March 11, 2020

View Archived Issues

'Gut bug' has intratumoral effects

Decoy exosomes fight bacterial toxin

AbbVie begins first-in-human study of ABBV-184 in previously treated AML and NSCLC

NCI selects Curadigm's Nanoprimer technology for characterization

Mesoblast to evaluate remestemcel-L for treatment of COVID-19 lung disease

Brilacidin to be tested against COVID-19

FDA clears IND applications for phase I study of CAD-9303 in schizophrenia

Nuclear NR4A3 expression as novel diagnostic biomarker of ACC-SG

SATB2 as novel biomarker of neuroendocrine differentiation in gynecological tumors

Broadly neutralizing antibody plus latency reversing treatment evaluated in HIV trial

Novel 18F-labeled tryptophan analogue as a PET imaging probe for Shh medulloblastoma

GEMoaB initiates first-in-human study of UniCAR-T-CD123 in acute leukemias

Chinese researchers patent JAK inhibitors

Rudong Ringene Pharmaceuticals divulges FGFR inhibitors

AZD-2373 begins first-in-human trial in healthy male subjects of African ancestry

KeyBioscience discloses new compounds for diabetes

Beijing Yuezhikangtai Biomedicines presents new tyrosine kinase inhibitors

Beijing Scitech-Mq Pharmaceuticals identifies VEGFR-2 and CSF-1R inhibitors

Researchers debut open-source platform for in silico small molecule screening

Neoantigen-rich murine melanoma cell model devised to study checkpoint inhibitor responses

First phase I study of cannabinol cream INM-755 completes enrollment

Gilead presents 96-week data from DISCOVER trial of Descovy for PrEP

Tiziana accelerates development of TZLS-501 for COVID-19

Novo Nordisk initiates phase I study of NNC0472-0147 for type 2 diabetes

Nucana reports preliminary data from phase II study of Acelarin in ovarian cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....